Qualitative semi-structured interview study exploring experiences of nine patients (six women, three men, ages 33–65) using semaglutide for weight loss in a rural Danish municipality. Identifies themes of social stigma (being suspected of taking 'the meds'), ambivalence about pharmaceutical weight management, and the lived experience of appetite suppression and gastrointestinal side effects. Provides patient-centered perspective on semaglutide's psychosocial dimensions—capturing how rural patients navigate the social context of GLP-1 RA therapy in a setting where pharmaceutical obesity treatment carries cultural complexity.
Guldhammer, Asbjørn; Drivsholm, Thomas; Tomova-Olsen, Sofie Amalie; Tranberg Jensen, Katrine